About AKASA
AKASA is a company based in San Francisco (United States) founded in 2018 by Ben Beadle Ryby, Andy Atwal, Malinka Walaliyadde, and Varun Ganapathi. AKASA has raised $80 million across 2 funding rounds from investors including Andreessen Horowitz, BOND and Costanoa. The company has 46 employees as of December 31, 2022. AKASA offers products and services including AKASA Platform, Authorization Advisor, Medical Coding, and Claim Status. AKASA operates in a competitive market with competitors including iMedX, Xifin, Infinx, Plusgrade and R1 RCM, among others.
- Headquarter San Francisco, United States
- Employees 46 as on 31 Dec, 2022
- Founders Ben Beadle Ryby, Andy Atwal, Malinka Walaliyadde, Varun Ganapathi
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$80 M (USD)
in 2 rounds
-
Latest Funding Round
$60 M (USD), Series B
Mar 23, 2021
-
Investors
Andreessen Horowitz
& 3 more
-
Employee Count
46
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AKASA
AKASA offers a comprehensive portfolio of products and services, including AKASA Platform, Authorization Advisor, Medical Coding, and Claim Status.
Generative AI for healthcare revenue cycle management
AI assistant for patient access teams
GenAI for accurate medical coding recommendations
Automated tracking of claim status information
People of AKASA
Unlock access to complete
Unlock access to complete
Funding Insights of AKASA
AKASA has successfully raised a total of $80M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AKASA
AKASA has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Andreessen Horowitz, BOND and Costanoa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
Investments in multiple sectors are made by Bond Capital.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on early stage fintech, data, AI, and security companies
|
Locked | Locked | Locked |
Investor details for AKASA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AKASA
Investment portfolio details for AKASA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AKASA
Detailed financials for AKASA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Akasa Comparisons
Peer comparison for AKASA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AKASA
AKASA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iMedX, Xifin, Infinx, Plusgrade and R1 RCM, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Revenue cycle management platform is provided to healthcare providers.
|
|
| Locked | Locked | Locked |
Cloud-based billing & revenue cycle management solutions for diagnostic service providers
|
|
| Locked | Locked | Locked |
Revenue cycle management platform for healthcare is provided.
|
|
| Locked | Locked | Locked |
SaaS revenue management solutions are offered to airlines for optimization.
|
|
| Locked | Locked | Locked |
End-to-end revenue cycle management is provided for healthcare organizations.
|
Detailed competitors of AKASA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Akasa
Complete news archive for AKASA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AKASA
AKASA was founded in 2018 and raised its 1st funding round 2 years after it was founded.
AKASA is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Malinka Walaliyadde is the current CEO of AKASA. They have also founded this company.
AKASA is a funded company, having raised a total of $80M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at AKASA is 46.
AKASA was founded in 2018 and is headquartered in San Francisco, United States. Automation solutions for revenue cycle management in the healthcare sector are developed and offered. Existing workflows are evaluated to identify key steps and decision points, enabling more accurate performance of reimbursement activities. The Unified Automation platform is designed to facilitate faster collection of reimbursements at reduced costs for organizations.
AKASA offers AKASA Platform, Authorization Advisor, Medical Coding, and Claim Status.
AKASA has 4 investors. Key investors include Andreessen Horowitz, BOND, Costanoa, and Jim Momtazee.